Indomethacin with or without prophylactic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial.
Elmunzer JB, Foster LD, Serrano J, Cote GA, Edmundowicz SA, Wani S et al, on behalf of the SVI Study Group.
Lancet 2024; 403: 450-458.
The addition of a routine stent further reduced the risk of pancreatitis by 3.6 per cent (95 per cent confidence interval 0.6 to 6.6 per cent, P=0.18 for non-inferiority) in high risk patients in this study of 1950 procedures. Safety profiles were similar.
Comment: The answer is clear but the study did not include a cost benefit analysis, and stents are expensive.
3 May 2024
Read paperAcademy
Part of the charitable activity of the Foundation, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
